344 related articles for article (PubMed ID: 27028982)
1. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.
Uguz F
J Clin Psychopharmacol; 2016 Jun; 36(3):244-52. PubMed ID: 27028982
[TBL] [Abstract][Full Text] [Related]
2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs and breastfeeding.
Klinger G; Stahl B; Fusar-Poli P; Merlob P
Pediatr Endocrinol Rev; 2013; 10(3):308-17. PubMed ID: 23724438
[TBL] [Abstract][Full Text] [Related]
6. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
[TBL] [Abstract][Full Text] [Related]
7. Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
Al-Dhaher Z; Kapoor S; Saito E; Krakower S; David L; Ake T; Kane JM; Correll CU; Carbon M
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):458-70. PubMed ID: 27093218
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.
Pozzi M; Cattaneo D; Baldelli S; Fucile S; Capuano A; Bravaccio C; Sportiello L; Bertella S; Auricchio F; Bernardini R; Ferrajolo C; Guastella G; Mani E; Carnovale C; Pisano S; Rafaniello C; Riccio MP; Rizzo R; Scuderi MG; Sperandeo S; Villa L; Pascotto A; Molteni M; Rossi F; Radice S; Clementi E
Eur J Clin Pharmacol; 2016 Mar; 72(3):285-93. PubMed ID: 26613956
[TBL] [Abstract][Full Text] [Related]
9. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
10. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
11. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
12. Weight gain and antipsychotics: a drug safety review.
Musil R; Obermeier M; Russ P; Hamerle M
Expert Opin Drug Saf; 2015 Jan; 14(1):73-96. PubMed ID: 25400109
[TBL] [Abstract][Full Text] [Related]
13. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
Vuk A; Kuzman MR; Baretic M; Osvatic MM
Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
[TBL] [Abstract][Full Text] [Related]
14. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review.
Simon V; van Winkel R; De Hert M
J Clin Psychiatry; 2009 Jul; 70(7):1041-50. PubMed ID: 19653979
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.
Cohen D; Bonnot O; Bodeau N; Consoli A; Laurent C
J Clin Psychopharmacol; 2012 Jun; 32(3):309-16. PubMed ID: 22544019
[TBL] [Abstract][Full Text] [Related]
16. Clinical utilization of atypical antipsychotics in pregnancy and lactation.
Gentile S
Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376
[TBL] [Abstract][Full Text] [Related]
17. Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Proença P; Monteiro C; Mustra C; Claro A; Franco J; Corte-Real F
J Anal Toxicol; 2020 Dec; 44(8):915-922. PubMed ID: 32780823
[TBL] [Abstract][Full Text] [Related]
18. Updating the Comparative Evidence on Second-Generation Antipsychotic Use With Schizophrenia.
McDonagh MS; Dana T; Selph S; Devine EB; Cantor A; Bougatsos C; Blazina I; Grusing S; Fu R; Haupt DW
Psychiatr Res Clin Pract; 2020 Dec; 2(2):76-87. PubMed ID: 36101867
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
